Omega-3 Fatty Acids (EPA/DHA)
fatty-acid · also known as Fish oil, EPA, DHA, Omega-3
This is general information, not medical advice. Supplements can interact with medicines and health conditions. Always check with your doctor or pharmacist before starting or changing supplements.
What it is
Omega-3 fatty acids -- primarily EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) -- are polyunsaturated fats found mainly in fatty fish and algae, used by the body to build cell membranes and to produce anti-inflammatory signalling molecules. Most people eating a typical Western diet get little EPA/DHA, which is why fish oil and algae-oil supplements are among the most widely used supplements. People take omega-3 supplements mainly to lower triglycerides, support joint comfort, and sometimes as an adjunct for mood; evidence for direct prevention of heart attacks or strokes in the general population is weaker and mixed. Supplements are sold in the natural triglyceride form found in fish oil, or as concentrated ethyl-ester preparations; the two forms differ modestly in how well they are absorbed. At the high doses used in some cardiovascular trials, omega-3 supplementation has also been linked to an increased risk of atrial fibrillation, so more is not automatically better or safer.
| Form | Elemental fraction | Notes |
|---|---|---|
| Triglyceride-form fish oil | n/a | The natural form found in fish oil as consumed in food; moderately better absorbed than ethyl-ester concentrates, especially when not taken with a high-fat meal. |
| Ethyl ester concentrate | n/a | A concentrated form used in many high-potency and prescription products; requires an extra enzymatic hydrolysis step for absorption and depends more on being taken with a fat-containing meal to reach bioavailability comparable to triglyceride-form oil. |
Evidence-based benefits
- Grade A· Strong evidence[1]
Omega-3 supplementation lowers triglycerides in a dose-dependent manner, with larger reductions at higher doses (above roughly 2 g/day) and in people with elevated triglycerides.
A continuous dose-response meta-analysis of randomised controlled trials found an approximately linear relationship between omega-3 intake and triglyceride reduction, with the largest reductions in people with hyperlipidemia or overweight/obesity given medium-to-high doses (>2 g/day); effects on LDL cholesterol were smaller and more mixed.
- Grade B· Limited evidence[1]
Omega-3 supplementation modestly reduces joint tenderness, morning stiffness, and NSAID use in people with rheumatoid arthritis.
A meta-analysis of randomised controlled trials in rheumatoid arthritis found omega-3 supplementation reduced tender joint count, morning stiffness, and NSAID consumption compared with placebo; effect sizes were modest and the authors noted variable trial quality.
- Grade B· Limited evidence[1]
Omega-3 supplementation produces a modest improvement in depressive symptoms, particularly in people with a diagnosed depressive disorder.
A dose-response meta-analysis found each additional 1 g/day of omega-3 modestly improved depressive symptoms (moderate-certainty evidence), with the largest average benefit around 1.5 g/day in people with existing depression; effects in people without a depression diagnosis were smaller.
Risks & contraindications
- Grade A· Strong evidence[1]
At doses above roughly 1 g/day, omega-3 supplementation is associated with a dose-dependent increase in atrial fibrillation risk.
A meta-analysis of cardiovascular outcome trials found omega-3 treatment increased atrial fibrillation risk overall (roughly a 24-25% relative increase versus placebo), with a clearer dose-dependent pattern at doses above 1 g/day; this signal was strongest in trials using purified, high-dose prescription-strength formulations rather than typical lower-dose over-the-counter supplements.
- Grade A· Strong evidence[1]
Omega-3 supplementation does not meaningfully increase overall bleeding risk, including alongside antiplatelet or anticoagulant medication, though high-dose purified EPA may carry a small additional risk.
A 2024 meta-analysis of randomised controlled trials found omega-3 polyunsaturated fatty acids were not associated with a significant increase in major bleeding overall, including in people also taking antiplatelet or anticoagulant drugs; a small additional bleeding risk was seen specifically with high-dose purified EPA, described by the authors as of modest clinical significance.
Dosage & how to take it
- Triglyceride-form fish oil: 1–3 g/day, any time of day, with food. Combined EPA+DHA per day. Take with a meal containing fat to improve absorption and reduce fishy aftertaste/reflux.
- Ethyl ester concentrate: 1–3 g/day, any time of day, with food. Combined EPA+DHA per day. Absorption is more dependent on co-ingesting dietary fat than the triglyceride form, so consistent dosing with food matters more.
Interactions
Bile acid sequestrants like cholestyramine work by binding bile acids in the intestine, and bile acids are also what your gut needs to package and absorb dietary fats, including omega-3 fish oil, into a form it can absorb. A clinical review of this drug class specifically documents this bile-acid-dependent absorption mechanism for fat-soluble vitamins, recommending they be taken a full 4 hours before the sequestrant dose; a separate clinical reference on cholestyramine specifically gives the more general rule of spacing other oral substances 1 hour before or 4 hours after it. Neither source studies omega-3 fatty acids by name, but the same digestive step (bile-acid-dependent micelle formation for dietary lipids) applies to omega-3, so the same precaution is a reasonable extension of that mechanism rather than something directly tested in a fish-oil-specific trial. Rather than track two slightly different windows, the safest and simplest instruction is to keep a full 4-hour gap between your omega-3 dose and your sequestrant dose, on either side.
Take at least 4h apart from Bile acid sequestrants.
Omega-3 fish oil has its own mild antiplatelet effect, so combining it with a vitamin K antagonist like warfarin can, in theory, add to bleeding risk on top of the medication's own anticoagulant effect. The evidence for this in practice is mixed: a case report described a patient's INR rising from 2.8 to 4.3 after she doubled her fish oil dose to 2,000 mg/day, but a larger retrospective study of 573 warfarin users found fish and krill oil use did not significantly change time-in-therapeutic-range or bleeding rates at typical doses. Omega-3 is not a reason to avoid warfarin, but if you take both, keep your dose consistent, mention it to whoever manages your INR monitoring, and get an INR check if you change your omega-3 dose meaningfully or notice unusual bruising or bleeding.
Our medication coverage is not exhaustive. Absence of a warning here is not evidence of safety. Always confirm with your pharmacist.
Where to buy
Checking current prices…